Ndayisaba G, Yeka A, Asante KP, Grobusch MP, et al. Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa. Malar J 2021;20:478.
PMID: 34930267